The role of nitric oxide in inflammation

被引:153
作者
Lyons, CR [1 ]
机构
[1] UNIV NEW MEXICO, CTR HLTH SCI, CANC RES & TREATMENT CTR, ALBUQUERQUE, NM 87131 USA
来源
ADVANCES IN IMMUNOLOGY, VOL 60 | 1995年 / 60卷
关键词
D O I
10.1016/S0065-2776(08)60589-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This chapter examines the multiple roles that nitric oxide (NO) may play during the inflammatory response. The majority of data implicating a role for NO in inflammation is based on experiments using nitric oxide synthase inhibitors. Inflammation results from increases in vascular flow, alterations in endothelium that can lead to plasma protein and leukocyte extravasation, and finally, the emigration of leukocytes from the circulation to the site of injury with resultant activation of effector cell mechanisms. There is evidence that NO can play a role during each stage of inflammation; the chapter discusses NO in the context of each of these stages. Conflicting data exist in the literature regarding the role of NO during inflammation. Some conflicts arise because of differences in the experimental systems studied such as in the animal species used or in the type of inflammatory stimulus. However, other differences may represent distinct physiologic and pathologic effects of NO during different phases of inflammation. NO plays a multifaceted role in all phases of the inflammatory immune response depending on the source and quantity of NO produced. It is important in the development of therapeutic modalities based on NO biochemistry and biology to take all roles of NO into consideration when designing potential treatments. © 1995 Academic Press Inc.
引用
收藏
页码:323 / 371
页数:49
相关论文
共 159 条
[1]  
Abu-Soud H.M., Stuehr D.J., Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer, Proc. Natl. Acad. Sci. USA, 90, pp. 10769-10772, (1993)
[2]  
Adams L.B., Franzblau S.G., Vavrin Z., Hibbs J.B., Krahenbuhl J.L., L-Arginine dependent macrophage effector functions inhibit metabolic activity of Mycobacterium leprae, J. Immunol., 147, pp. 1642-1646, (1991)
[3]  
Adams L.B., Hibbs J.B., Taintor R.R., Krahenbuhl J.L., Microbostatic effect of murine-activated macrophages for Toxoplasma gondii: Role for synthesis of inorganic nitrogen oxides from l-arginine, J. Immunol., 144, pp. 2725-2729, (1990)
[4]  
Albina J., Cui S., Mateo R.B., Reichner J.S., Nitric oxide-mediated apoptosis in murine peritoneal macrophages, J. Immunol., 50, pp. 5080-5085, (1993)
[5]  
Albina J.E., Abate J.A., Henry W., Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-gamma in the induction of the nitric oxide-synthesizing pathway, J. Immunol., 147, pp. 144-148, (1991)
[6]  
Albina J.E., Mills C.D., Henry W.L., Caldwell M.D., Temporal expression of different pathways of I-arginine metabolism in healing wounds, J. Immunol., 144, pp. 3877-3880, (1990)
[7]  
Albina J.E., Mills C.D., Barbul A., Thirkill C.E., Henry W.L., Mastrofrancesco B., Caldwell M.D., Arginine metabolism in wounds, Am. J. Physiol., 17, pp. E459-E467, (1988)
[8]  
Ramadi A.-B.K., Meissler J., Huang D., Eisenstein T.K., Immunosuppression induced by nitric oxide and its inhibition by interleukin-4, Eur. J. Immunol., 22, pp. 2249-2254, (1992)
[9]  
Alspaugh J.A., Granger D., Inhibition of Cryptococcus neoformans replication by nitrogen oxides supports the role of these molecules as effectors of macrophage-mediated cytostasis, Infect. Immun., 59, pp. 2291-2296, (1991)
[10]  
Andrews F.J., Malcontenti-Wilson C., O'Brien P.E., Protection against gastric ischemia-reperfusion injury by nitric oxide generators, Digestive Dis. Sci., 39, pp. 366-373, (1994)